Correlation Between Stryker and Novacyt SA
Can any of the company-specific risk be diversified away by investing in both Stryker and Novacyt SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stryker and Novacyt SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stryker and Novacyt SA, you can compare the effects of market volatilities on Stryker and Novacyt SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stryker with a short position of Novacyt SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stryker and Novacyt SA.
Diversification Opportunities for Stryker and Novacyt SA
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Stryker and Novacyt is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Stryker and Novacyt SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novacyt SA and Stryker is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stryker are associated (or correlated) with Novacyt SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novacyt SA has no effect on the direction of Stryker i.e., Stryker and Novacyt SA go up and down completely randomly.
Pair Corralation between Stryker and Novacyt SA
Considering the 90-day investment horizon Stryker is expected to generate 2.0 times less return on investment than Novacyt SA. But when comparing it to its historical volatility, Stryker is 5.33 times less risky than Novacyt SA. It trades about 0.07 of its potential returns per unit of risk. Novacyt SA is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 82.00 in Novacyt SA on September 19, 2024 and sell it today you would lose (12.00) from holding Novacyt SA or give up 14.63% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Stryker vs. Novacyt SA
Performance |
Timeline |
Stryker |
Novacyt SA |
Stryker and Novacyt SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Stryker and Novacyt SA
The main advantage of trading using opposite Stryker and Novacyt SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stryker position performs unexpectedly, Novacyt SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novacyt SA will offset losses from the drop in Novacyt SA's long position.Stryker vs. Boston Scientific Corp | Stryker vs. Abbott Laboratories | Stryker vs. Medtronic PLC | Stryker vs. DexCom Inc |
Novacyt SA vs. Aethlon Medical | Novacyt SA vs. Bone Biologics Corp | Novacyt SA vs. Tivic Health Systems | Novacyt SA vs. Cytosorbents Crp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |